Open Access

[Retracted] miR‑200b and miR‑200c co‑contribute to the cisplatin sensitivity of ovarian cancer cells by targeting DNA methyltransferases

  • Authors:
    • Jue Liu
    • Xiaobo Zhang
    • Yuliang Huang
    • Qunfeng Zhang
    • Jianbin Zhou
    • Xiaodi Zhang
    • Xiaoxu Wang
  • View Affiliations

  • Published online on: March 4, 2025     https://doi.org/10.3892/ol.2025.14951
  • Article Number: 209
  • Copyright : © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

April-2025
Volume 29 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Liu J, Zhang X, Huang Y, Zhang Q, Zhou J, Zhang X and Wang X: [Retracted] miR‑200b and miR‑200c co‑contribute to the cisplatin sensitivity of ovarian cancer cells by targeting DNA methyltransferases . Oncol Lett 29: 209, 2025.
APA
Liu, J., Zhang, X., Huang, Y., Zhang, Q., Zhou, J., Zhang, X., & Wang, X. (2025). [Retracted] miR‑200b and miR‑200c co‑contribute to the cisplatin sensitivity of ovarian cancer cells by targeting DNA methyltransferases . Oncology Letters, 29, 209. https://doi.org/10.3892/ol.2025.14951
MLA
Liu, J., Zhang, X., Huang, Y., Zhang, Q., Zhou, J., Zhang, X., Wang, X."[Retracted] miR‑200b and miR‑200c co‑contribute to the cisplatin sensitivity of ovarian cancer cells by targeting DNA methyltransferases ". Oncology Letters 29.4 (2025): 209.
Chicago
Liu, J., Zhang, X., Huang, Y., Zhang, Q., Zhou, J., Zhang, X., Wang, X."[Retracted] miR‑200b and miR‑200c co‑contribute to the cisplatin sensitivity of ovarian cancer cells by targeting DNA methyltransferases ". Oncology Letters 29, no. 4 (2025): 209. https://doi.org/10.3892/ol.2025.14951